linopristin
Small moleculeexperimental
Linopristin is an antibiotic of the streptogramin B class. It has been described as a pristinamycin IA derivative, though it is actually more similar to quinupristin. NCATS Inxight describes it as a chemically modified version of quinupristin. — Wikipedia
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Oct 1, 2007 (NCT00653172)
Timeline
2000s
- Jan 1, 2007
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- 50S ribosomal protein L2INHIBITOR
rplB inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaLinopristin ↗
Also known as
- linopristin
- linopristin
- nxl103
- nxl103
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00949130 | Phase 2 | Nov 1, 2009 | Novexel Inc |
| NCT00653172 | Phase 2 | Oct 1, 2007 | Novexel Inc |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Novexel Inc | For profit | 2 | 2 | 1 | 2007 |
1 organizations
Page 1 / 1